Perceptive Advisors as of Sept. 30, 2013
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 101 positions in its portfolio as reported in the September 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aegerion Pharmaceuticals | 16.2 | $200M | 2.3M | 85.75 | |
| Sarepta Therapeutics (SRPT) | 10.6 | $131M | 2.8M | 47.22 | |
| Onyx Pharmaceuticals | 5.6 | $70M | 557k | 124.70 | |
| Acelrx Pharmaceuticals | 5.1 | $63M | 5.9M | 10.78 | |
| Tesaro | 4.8 | $59M | 1.5M | 38.74 | |
| Celgene Corporation | 4.6 | $56M | 365k | 154.14 | |
| Gilead Sciences (GILD) | 4.4 | $54M | 864k | 62.87 | |
| Neurocrine Biosciences (NBIX) | 4.2 | $52M | 4.6M | 11.32 | |
| Repros Therapeutics | 3.6 | $45M | 1.7M | 26.80 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.8 | $34M | 452k | 75.82 | |
| iShares NASDAQ Biotechnology Index (IBB) | 2.5 | $30M | 145k | 209.60 | |
| Questcor Pharmaceuticals | 1.8 | $22M | 376k | 58.00 | |
| EXACT Sciences Corporation (EXAS) | 1.7 | $21M | 1.7M | 11.80 | |
| Mylan | 1.4 | $18M | 460k | 38.17 | |
| CIGNA Corporation | 1.4 | $17M | 223k | 76.86 | |
| Neptune Technologies Bioreso | 1.4 | $17M | 5.4M | 3.18 | |
| ACADIA Pharmaceuticals (ACAD) | 1.4 | $17M | 611k | 27.47 | |
| Vanda Pharmaceuticals (VNDA) | 1.3 | $16M | 1.4M | 10.95 | |
| Synta Pharmaceuticals | 1.2 | $15M | 2.4M | 6.31 | |
| Health Net | 1.2 | $14M | 454k | 31.70 | |
| Arena Pharmaceuticals | 1.1 | $14M | 2.6M | 5.27 | |
| Pacira Pharmaceuticals (PCRX) | 1.1 | $13M | 272k | 48.07 | |
| Capital Senior Living Corporation | 1.1 | $13M | 614k | 21.15 | |
| Covidien | 1.0 | $13M | 211k | 60.94 | |
| Santarus | 1.0 | $12M | 532k | 22.59 | |
| Clovis Oncology | 1.0 | $12M | 195k | 60.80 | |
| Dyax | 0.9 | $12M | 1.7M | 6.86 | |
| Cell Therapeutics | 0.9 | $11M | 7.0M | 1.62 | |
| Anacor Pharmaceuticals In | 0.8 | $10M | 974k | 10.62 | |
| Amgen (AMGN) | 0.8 | $10M | 92k | 111.93 | |
| iShares Russell 2000 Index (IWM) | 0.8 | $10M | 97k | 106.61 | |
| Chelsea Therapeutics International | 0.8 | $10M | 3.4M | 2.99 | |
| Walgreen Company | 0.8 | $10M | 188k | 53.80 | |
| Sangamo Biosciences (SGMO) | 0.8 | $10M | 965k | 10.49 | |
| NPS Pharmaceuticals | 0.8 | $9.7M | 306k | 31.81 | |
| WellCare Health Plans | 0.8 | $9.2M | 132k | 69.74 | |
| Endocyte | 0.7 | $8.2M | 612k | 13.33 | |
| ISIS Pharmaceuticals | 0.6 | $7.2M | 193k | 37.54 | |
| Amarin Corporation (AMRN) | 0.5 | $6.4M | 1.0M | 6.32 | |
| InterMune | 0.4 | $4.6M | 300k | 15.38 | |
| Immunomedics | 0.4 | $4.6M | 738k | 6.20 | |
| D Stemline Therapeutics | 0.3 | $4.1M | 90k | 45.30 | |
| Array BioPharma | 0.3 | $3.6M | 573k | 6.22 | |
| Athersys | 0.3 | $3.5M | 2.2M | 1.64 | |
| Coronado Biosciences Inc. Common | 0.3 | $3.5M | 502k | 7.01 | |
| Infinity Pharmaceuticals (INFIQ) | 0.3 | $3.4M | 195k | 17.43 | |
| Anika Therapeutics (ANIK) | 0.3 | $3.4M | 144k | 23.89 | |
| pSivida | 0.3 | $3.2M | 772k | 4.11 | |
| Verastem | 0.2 | $3.0M | 241k | 12.45 | |
| Mazor Robotics Ltd. equities | 0.2 | $3.0M | 177k | 16.90 | |
| Medivation | 0.2 | $2.9M | 48k | 59.94 | |
| Neostem | 0.2 | $2.8M | 332k | 8.55 | |
| Vivus | 0.2 | $2.7M | 290k | 9.30 | |
| Champions Oncology | 0.2 | $2.7M | 1.6M | 1.75 | |
| Spectranetics Corporation | 0.2 | $2.6M | 154k | 16.80 | |
| Dex (DXCM) | 0.2 | $2.0M | 73k | 28.22 | |
| Keryx Biopharmaceuticals | 0.2 | $2.0M | 200k | 10.09 | |
| Mgc Diagnostics | 0.2 | $1.9M | 174k | 10.95 | |
| Celldex Therapeutics | 0.1 | $1.7M | 48k | 35.42 | |
| Anthera Pharmaceutcls | 0.1 | $1.7M | 432k | 4.02 | |
| MannKind Corporation | 0.1 | $1.7M | 290k | 5.70 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $1.4M | 191k | 7.28 | |
| Myriad Genetics (MYGN) | 0.1 | $1.4M | 58k | 23.50 | |
| Tekmira Pharmaceuticals Corporation | 0.1 | $1.1M | 159k | 6.98 | |
| Medgenics | 0.1 | $1.2M | 150k | 7.80 | |
| Uroplasty | 0.1 | $1.0M | 304k | 3.31 | |
| Oncothyreon | 0.1 | $994k | 483k | 2.06 | |
| Progenics Pharmaceuticals | 0.1 | $849k | 169k | 5.02 | |
| AVANIR Pharmaceuticals | 0.1 | $816k | 193k | 4.23 | |
| Transgenomic | 0.1 | $839k | 2.2M | 0.38 | |
| Repligen Corporation (RGEN) | 0.1 | $757k | 68k | 11.08 | |
| Nanosphere | 0.1 | $679k | 340k | 2.00 | |
| Vical Incorporated | 0.0 | $500k | 400k | 1.25 | |
| HeartWare International | 0.0 | $366k | 5.0k | 73.20 | |
| Acasti Pharma | 0.0 | $366k | 154k | 2.37 | |
| INSTRS INC Stemcells | 0.0 | $389k | 232k | 1.68 | |
| Astex Pharmaceuticals | 0.0 | $400k | 47k | 8.49 | |
| Neoprobe | 0.0 | $309k | 117k | 2.65 | |
| XenoPort | 0.0 | $274k | 48k | 5.68 | |
| Furiex Pharmaceuticals | 0.0 | $220k | 5.0k | 44.00 | |
| DaVita (DVA) | 0.0 | $131k | 2.3k | 56.71 | |
| LifePoint Hospitals | 0.0 | $140k | 3.0k | 46.74 | |
| AstraZeneca (AZN) | 0.0 | $140k | 2.7k | 51.85 | |
| Omnicare | 0.0 | $140k | 2.5k | 55.45 | |
| CVS Caremark Corporation (CVS) | 0.0 | $131k | 2.3k | 56.96 | |
| Aetna | 0.0 | $133k | 2.1k | 64.25 | |
| VCA Antech | 0.0 | $129k | 4.7k | 27.36 | |
| Magellan Health Services | 0.0 | $137k | 2.3k | 59.83 | |
| Alere | 0.0 | $135k | 4.4k | 30.47 | |
| Community Health Systems (CYH) | 0.0 | $142k | 3.4k | 41.58 | |
| AmSurg | 0.0 | $136k | 3.4k | 39.82 | |
| Hanger Orthopedic | 0.0 | $138k | 4.1k | 33.82 | |
| Centene Corporation (CNC) | 0.0 | $151k | 2.4k | 64.12 | |
| Molina Healthcare (MOH) | 0.0 | $128k | 3.6k | 35.65 | |
| Cutera (CUTR) | 0.0 | $110k | 12k | 8.87 | |
| Healthsouth | 0.0 | $144k | 4.2k | 34.37 | |
| Mednax (MD) | 0.0 | $138k | 1.4k | 100.36 | |
| Zeltiq Aesthetics | 0.0 | $124k | 14k | 9.05 | |
| Kythera Biopharmaceuticals I | 0.0 | $126k | 2.8k | 45.57 | |
| Axogen (AXGN) | 0.0 | $20k | 4.5k | 4.44 | |
| Combimatrix Corporation *w exp 05/01/ | 0.0 | $2.0k | 5.0k | 0.40 |
